Corticosteroid modulation of tissue responses to implanted sensors

Diabetes Technology and Therapeutics

Volumn 6, Issue 6, 2004, Pages 899-901

  Friedl, Karl E ^a  

^a U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; GLUCOSE; POLYGLACTIN; POLYVINYL ALCOHOL; PREDNISOLONE; VASCULOTROPIN; MICROSPHERE;

ANGIOGENESIS; ARTICLE; BIOCOMPATIBILITY; BIOSENSOR; BLOOD GLUCOSE MONITORING; DRUG RELEASE; ENCAPSULATION; FOREIGN BODY; FOREIGN BODY REACTION; GLUCOSE BLOOD LEVEL; HUMAN; HYDROGEL; IMPLANT; INFLAMMATION; MATERIAL COATING; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; TISSUE REACTION; ANIMAL; DRUG MONITORING; METHODOLOGY; NOTE; TISSUE DISTRIBUTION;

ADRENAL CORTEX HORMONES; ANIMALS; DRUG MONITORING; HUMANS; MICROSPHERES; TISSUE DISTRIBUTION;

EID: 12344275275     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2004.6.898     Document Type: Article

References (13)

1. Patil SD, Papadimitrakopoulos F, Burgess DJ: Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control. Diabetes Technol Ther 2004;6:887-897.
2. Hickey T, Kreutzer D, Burgess DJ, Moussy F: Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials 2002;23:1649-1656.
3. Gilligan BJ, Shults MC, Rhodes RK, Updike SJ: Evaluation of a subcutaneous glucose sensor out to 3 months in a dog model. Diabetes Care 1994;17:882-887.
4. Ward WK, Troupe JE: Assessment of chronically implanted subcutaneous glucose sensors in dogs: the effect of surrounding fluid masses. ASAIO J 1999;45:555-561.
5. Christenson L, Aebischer P, McMillan P, Galletti PM: Tissue reaction to intraperitoneal polymer implants: species difference and effects of corticoid and doxorubicin. J Biomed Mater Res 1989;23:705-718.
6. McGregor VP, Banarer S, Cryer PE: Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent hypoglycemia. Am J Endocrinol Metab 2002;282:E770-E777.
7. Gorsline J, Bradlow HL, Sherman MR: Triamcinolone acetonide 21-oic acid methyl ester: a potent local anti-inflammatory steroid without detectable systemic effects. Endocrinology 1985;116:263-273.
8. Ward WK, Wood MD, Casey HM, Quinn MJ, Federiuk IF: The effect of local subcutaneous delivery of vascular endothelial growth factor on the function of a chronically implanted amperometric glucose sensor. Diabetes Technol Ther 2004;6:137-145.
9. Ward WK, Slobodzian EP, Tiekotter KL, Wood MD: The effect of microgeometry, implant thickness and polyurethane chemistry on the foreign body response to subcutaneous implants. Biomaterials 2002;23:4185-4192.
10. Schuschereba ST, Brown J, Stuck BE, Marshall J: Untoward effects of high-dose methylprednisolone therapy on blood-retinal barrier closure, retinal hole repair, and long-term scarring. Proc SPIE 2001;4246:1-9.
11. Jung SP, Siegrist B, Wade MR, Anthony CT, Woltering EA: Inhibition of human angiogenesis with heparin and hydrocortisone. Angiogenesis 2001;4(3):175-186.
12. Hu WJ, Eaton JW, Tang L: Molecular basis of biomaterial-mediated foreign body reactions. Blood 2001;98:1231-1238.
13. Institute of Medicine: Monitoring Metabolic Status - Predicting Decrements in Physiological and Cognitive Performance. Washington, DC: The National Academies Press, 2004.